Celularity Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/71ef40a3-b811-41bf-a75c-cad032ff31ba/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-61.3M | 2025-01-01 – 2025-12-31 | evidence 0001493152-26-020424 |
| FY 2024 | $-38.4M | 2024-01-01 – 2024-12-31 | evidence 0001641172-25-009319 |
| FY 2023 | $-192.3M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-087886 |
| FY 2022 | $-25.6M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-011440 |
| FY 2021 | $-109.1M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-013004 |
| FY 2020 | $-151.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-22-013004 |
| FY 2019 | $-1.7M | 2019-01-01 – 2019-12-31 | evidence 0001213900-21-028849 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).